AxoGen (AXGN) in Focus: Stock Surges 25.0%

Zacks

AxoGen, Inc. (AXGN) was a big mover last session, as the company saw its shares rise over 25% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $3.35 to $3.64 since Dec 16.

This regenerative medicine company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in a trend either. Tuesday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

AxoGen currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked stocks in the broader medical sector include Cepheid (CPHD), Achillion Pharmaceuticals, Inc. (ACHN) and Align Technology Inc. (ALGN). All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



AXOGEN INC (AXGN): Free Stock Analysis Report

CEPHEID INC (CPHD): Free Stock Analysis Report

ACHILLION PHARMACEUTICALS INC (ACHN): Free Stock Analysis Report

ALIGN TECHNOLOGY INC (ALGN): Free Stock Analysis Report


Zacks Investment Research

Rates

View Comments (0)